Martin VanTrieste
SVP, Quality
Martin VanTrieste is senior vice president, Quality, responsible for all aspects of Quality Assurance, Quality Control, Compliance, Operational Excellence, and Environment, Health and Safety along with Training.
Prior to Amgen, VanTrieste was with Bayer HealthCare’s Biological Products Division as vice president of Worldwide Quality and Abbott Laboratories as the vice president of Quality Assurance for the Hospital Products Division. While at Abbott, VanTrieste held various positions in Quality, Operations, and Research and Development.
VanTrieste is a member of the board of directors of the Parenteral Drug Associations (PDA). He is the founder and first chairman of Rx-360 and is currently on its board of directors. Rx-360 is a nonprofit international supply chain organization that aims to enhance patient safety by increasing the security and quality of all parts of the supply chain.
VanTrieste holds a Pharmacy degree from Temple University School of Pharmacy in Philadelphia.
Prior to Amgen, VanTrieste was with Bayer HealthCare’s Biological Products Division as vice president of Worldwide Quality and Abbott Laboratories as the vice president of Quality Assurance for the Hospital Products Division. While at Abbott, VanTrieste held various positions in Quality, Operations, and Research and Development.
VanTrieste is a member of the board of directors of the Parenteral Drug Associations (PDA). He is the founder and first chairman of Rx-360 and is currently on its board of directors. Rx-360 is a nonprofit international supply chain organization that aims to enhance patient safety by increasing the security and quality of all parts of the supply chain.
VanTrieste holds a Pharmacy degree from Temple University School of Pharmacy in Philadelphia.